BIOCORYL 100 MG/ML

BIOCORYL 100 MG/ML
Product Description

Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies. 

Mana Pharma

  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)
Specifications
  • Details
    BIOCORYL 100 MG/ML Solution for injection (Procainamide Hydrochloride)
  • Selling Points
    Cardiovascular Health
  • Supplied from
    Spain
  • Measured In
    piece

Mana Pharma

  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)

More Products from Mana Pharma (4)

  • ANTICUDE

    Product ANTICUDE

    Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents and synthetic ones, in prolonged apnea and in any syndrome involving atony of the striated or smooth fibre musculature. It is also used in the diagnosis and treatment of myasthenia gravis and to aid in th...
  • Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia
  • Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemi...
  • Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia

Mana Pharma resources (1)

  • News Mana Pharma Positioning and differentiation in the sector

    Since the end of 2020, Mana Pharma, S.L. has played a key role in the distribution of Medicines for Special Situations (MSS) in Spain, contributing, in agreement with the Health Authorities, to alleviate the lack of supply of medicines that occur in our country.